866-997-4948(US-Canada Toll Free)

Domain Therapeutics - Product Pipeline Review - 2012

Published By :

Global Markets Direct

Published Date : Aug 2012

Category :

Therapeutic Area

No. of Pages : 35 Pages


Domain Therapeutics Product Pipeline Review 2012

Global Markets Directs pharmaceuticals report, Domain Therapeutics Product Pipeline Review 2012 provides data on the Domain Therapeuticss research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. 

This report is built using data and information sourced from Global Markets Directs proprietary databases, Domain Therapeuticss corporate website, SEC filings, investor presentations and featured press releases, both from Domain Therapeutics and industry-specific third party sources, put together by Global Markets Directs team. 

Scope

  • Domain Therapeutics Brief Domain Therapeutics overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of Domain Therapeutics human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Domain Therapeutics with complete description of the products developmental history, mechanism of action, therapeutic class, target and major milestones. 
  • Recent updates of the Domain Therapeuticss pipeline in the last quarter. 
  • Key discontinued and dormant projects. 
  • Latest news and deals relating to the products.

Reasons to buy

  • Evaluate Domain Therapeuticss strategic position with total access to detailed information on its product pipeline. 
  • Assess the growth potential of Domain Therapeutics in its therapy areas of focus. 
  • Identify new drug targets and therapeutic classes in the Domain Therapeuticss R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. 
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. 
  • Exploit collaboration and partnership opportunities with Domain Therapeutics. 
  • Avoid Intellectual Property Rights related issues. 
  • Explore the dormant and discontinued projects of Domain Therapeutics and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Domain Therapeutics; Domain Therapeutics Key Therapeutics; Domain Therapeutics Pipeline Overview and Promising Molecules; Domain Therapeutics News; Domain Therapeutics Latest Updates; Domain Therapeutics Pipeline; Domain Therapeutics Discontinued/Dormant Projects
Table of Contents

Table of Contents 2

List of Tables 4
List of Figures 4
Domain Therapeutics Snapshot 5
Domain Therapeutics Overview 5
Key Information 5
Key Facts 5
Domain Therapeutics Research and Development Overview 6
Key Therapeutic Areas 6
Domain Therapeutics Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products Monotherapy 9
Domain Therapeutics Pipeline Products Glance 10
Domain Therapeutics Early Stage Pipeline Products 10
Pre-Clinical Products/Combination Treatment Modalities 10
Discovery Products/Combination Treatment Modalities 11
Domain Therapeutics Drug Profiles 12
DT-0738 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
DT-1133 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
DT-1687 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
DT-2228 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
DT2208 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
GLP 1R PAMs 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Orphan GPCR 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Domain Therapeutics Pipeline Products by Route of Administration 19
Domain Therapeutics Pipeline Products By Mechanism of Action 20
Domain Therapeutics - Dormant Projects 21
Domain Therapeutics Locations And Subsidiaries 22
Head Office 22
Financial Deals Landscape 23
Domain Therapeutics, Deals Summary 23
Domain Therapeutics, Pharmaceuticals & Healthcare, Deal Details 24
Venture Financing 24
Domain Therapeutics Raises $2.5 Million In Venture Financing 24
Domain Therapeutics Secures $3 Million In Venture Financing Round 26
Faust Pharma Secures $10 Million In Series C Financing Round 28
Partnerships 30
Domain Therapeutics Enters Into Research Agreement With Takeda 30
Domain Therapeutics Enters Into Research Agreement With Takeda Pharma 31
Licensing Agreements 32
Domain Therapeutics Enters Into Licensing Agreement With Merck Serono 32

Appendix 34
Methodology 34
Coverage 34
Secondary Research 34
Primary Research 34
Expert Panel Validation 34
Contact Us 35
Disclaimer 35

List of Table


Domain Therapeutics, Key Information 5
Domain Therapeutics, Key Facts 5
Domain Therapeutics Pipeline by Indication, 2012 7
Domain Therapeutics Pipeline by Stage of Development, 2012 8
Domain Therapeutics Monotherapy Products in Pipeline, 2012 9
Domain Therapeutics Pre-Clinical, 2012 10
Domain Therapeutics Discovery, 2012 11
Domain Therapeutics Pipeline By Route of Administration, 2012 19
Domain Therapeutics Pipeline Products By Mechanism of Action, 2012 20
Domain Therapeutics - Dormant Developmental Projects,2012 21
Domain Therapeutics, Deals Summary 23
Domain Therapeutics Raises $2.5 Million In Venture Financing 24
Domain Therapeutics Secures $3 Million In Venture Financing Round 26
Faust Pharma Secures $10 Million In Series C Financing Round 28
Domain Therapeutics Enters Into Research Agreement With Takeda 30
Domain Therapeutics Enters Into Research Agreement With Takeda Pharma 31
Domain Therapeutics Enters Into Licensing Agreement With Merck Serono 32

List of Chart


Domain Therapeutics - Pipeline by Indication, 2012 7
Domain Therapeutics - Pipeline by Stage of Development, 2012 8
Domain Therapeutics - Monotherapy Products in Pipeline, 2012 9
Domain Therapeutics - Pipeline Products By Mechanism of Action, 2012 20

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *